Molecular diagnostics and personalized treatment plans for cancer patients
Agendia has raised €65M across 2 funding rounds from 1 investor, most recently a Series D+ round in May 2012. Based in Amsterdam, Netherlands; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2012-05-01 | Series D+ | €49M | ING Bank Corporate Finance | View deal → |
| 2009-09-01 | Growth/Late | €16M | ING Bank Corporate Finance | View deal → |
